Circulating Peptidome and Tumor-Resident Proteolysis

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Proteases are enzymes crucial for cellular functions and implicated in cancer initiation, progression, and metastasis.
• Human proteases are classified into five catalytic families: metalloprotease, serine protease, cysteine protease, aspartic peptidase, and threonine peptidase.
• Cancer degradomes encompass proteases, inhibitors, and substrates, influencing tumor development and suppression.

Purpose of the Study:

• To review the roles of different human protease families in tumorigenesis, migration, and metastasis.
• To explore the impact of cancer degradomes on cancer promotion and suppression.
• To discuss the potential of tumor peptidomes as cancer biomarkers.

Main Methods:

• Review of existing literature on human protease functions in cancer.
• Analysis of cancer degradome profiling approaches.
• Examination of peptidome study methodologies and their applications.

Main Results:

• Human proteases play significant roles in critical cellular processes and cancer pathogenesis.
• Cancer-associated protein degradation profiles (tumor peptidomes) are valuable sources for biomarker discovery.
• Circulating peptides can serve as biomarkers, reflecting protease activity during cancer progression.

Conclusions:

• Understanding cancer-associated proteases, degradomes, and peptidomes enhances knowledge of cancer biology.
• These components offer potential for improved cancer diagnosis, evaluation, and therapeutic strategies.
• Further research in this area can inspire novel approaches in cancer research and treatment.